Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies

•High-grade irAEs occur in around 15% of total immunotherapy treated NSCLC patients.•Respiratory related irAEs are the most popular among patients who developed high-grade irAEs.•Specific gene mutations were associated with the occurrence of high-grade irAEs.•Different subtypes of NSCLC have unique...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lung cancer 2024-12, Vol.25 (8), p.e379-e388
Hauptverfasser:	Smith, Margaret R., Wang, Yuezhu, Dixon, Caroline B., D'Agostino, Ralph, Liu, Yin, Ruiz, Jimmy, Oliver, George, Miller, Lance D., Topaloglu, Umit, Chan, Michael D., Farris, Michael, Su, Jing, Mileham, Kathryn F., Li, Wencheng, Grayson, Jason M., Lycan, Thomas, Xing, Fei
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology Female Humans Immune Checkpoint Inhibitors - adverse effects Immune Checkpoint Inhibitors - therapeutic use Immune related adverse effect Immunotherapy Immunotherapy - methods Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Male Middle Aged Mutation Nonsmall cell lung cancer Retrospective Studies Sequencing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!